Showing results (291-300 of 378) with videos related to

Sort By:
Pageof 38
Leukemia|August 27, 2010
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapiesM A Dimopoulos, E Kastritis, D Christoulas, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2010
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancerAristotelis Bamias, M Karina, P Papakostas, et al.
Journal of Ovarian Research|November 2, 2021
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapyM Liontos, A Andrikopoulou, K Koutsoukos, et al.
Urology|December 31, 1997
Oral estramustine and oral etoposide for hormone-refractory prostate cancerM A Dimopoulos, C Panopoulos, C Bamia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapyA Bamias, E Efstathiou, L A Moulopoulos, et al.
Leukemia|September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCTE Terpos, D Christoulas, E Kastritis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II studyN Androulakis, C Kourousis, M A Dimopoulos, et al.
British Journal of Cancer|June 1, 2013
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case seriesF Zagouri, T N Sergentanis, V Koutoulidis, et al.
Journal of Surgical Oncology|October 31, 2009
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancerC S Boskos, C Liacos, D Korkolis, et al.
Annals of Internal Medicine|May 1, 1982
Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patientsJ U Gutterman, S Fine, J Quesada, et al.
Pageof 38